Topic: Acomplia
While not approved by the MedCEU: Obesity:
The new diet pill Acomplia is generating great interest among the overweight patients on this pretext. Apart for keeping a person free from excess weight, the diet pill Acomplia also helps a person in stopping his or her?s urges for smoking. Acomplia ...
Obesity is defined as "the condition of an excessively high amount of body fat or adipose tissue in relation to lean body mass." 1 A more commonly-known definition of obesity is that of an individual's weight being 30% or more above what ...
Anti-obesity drugs are medications formulated to reduce or control weight. Depression that might be severe enough to cause suicidal thoughts in some patients was one of the reasons why the United States' Food and Drug Administration refused to approve a drug called ...
CHICAGO (Reuters) - A compound similar to Sanofi-Aventis' once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without causing psychological side effects, U.S. researchers said on Monday.Like Acomplia, the drug targets cannabinoid receptors ...
The article looks at the suicide concerns over the weight-loss drug Acomplia, manufactured by Sanofi-Aventis. The drug has been approved by the British National Institute for Health and Clinical Excellence (NICE) and it is licensed in the Great Britain for the treatment ...
The article announces personnel changes at Edelman, including Mike Kan as managing director of Edelman Health in Europe and Steven Spurr as managing director of Edelman's pharma team in Great Britain. Healthcare ON THE AGENDA Suicide fears over weight-loss drug In a ...
The article reports on the decision of Sanofi-Aventis to discontinue all trials of its anti-obesity drug rimonabant called Acomplia. 4 14 November 2008 www.lienlthrnriTepiiblic.com SS NEWS 3 Premises are key when bidding for contracts Med eco nom ics, page 46 COMMISSIONING Professor ...
Arena Pharmaceuticals said today that its experimental obesity drug met pre-defined targets for safety and effectiveness in a large study. The drug, called lorcaserin, fared well on a key measure for the FDA: A few years back, the Sanofi-Aventis drug sold in ...
?Booming Global Obesity Drug Market?, our latest research on the obesity market, states that the prevalence of obesity is increasing globally at alarming rates. Obesity drugs market has shown a radical growth in recent times but in contrast, the market for weight ...
